Polymer Capital Management US LLC acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 3,945 shares of the company's stock, valued at approximately $641,000.
Several other large investors also recently modified their holdings of CLX. Vanguard Group Inc. raised its stake in Clorox by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock worth $2,518,517,000 after acquiring an additional 124,428 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Clorox by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock worth $501,925,000 after purchasing an additional 69,969 shares in the last quarter. Norges Bank bought a new position in Clorox during the 4th quarter valued at about $259,041,000. FMR LLC boosted its position in Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company's stock valued at $221,163,000 after buying an additional 585,526 shares in the last quarter. Finally, Amundi boosted its position in Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock valued at $165,816,000 after buying an additional 308,234 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.
Clorox Trading Up 0.3 %
Shares of NYSE CLX traded up $0.45 during midday trading on Friday, reaching $141.35. 1,249,590 shares of the stock were exchanged, compared to its average volume of 1,295,815. The company has a market capitalization of $17.41 billion, a price-to-earnings ratio of 38.62, a P/E/G ratio of 2.62 and a beta of 0.61. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The business has a 50-day simple moving average of $147.39 and a two-hundred day simple moving average of $157.24.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.45%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is 133.33%.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Wells Fargo & Company dropped their price target on Clorox from $161.00 to $155.00 and set an "equal weight" rating for the company in a report on Wednesday, April 2nd. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Barclays lowered their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research report on Friday. Evercore ISI raised their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $156.75.
Check Out Our Latest Research Report on CLX
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.